{"title":"Usefulness of transnasal volume-reduction treatment for nasal tumors by ultrasonic emulsification suction in 2 dogs.","authors":"Shinya Mizutani, Yuko Mizutani, Yoshimichi Goda, Taketoshi Asanuma, Shidow Torisu","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>Intranasal tumors in dogs are rare neoplastic diseases with obvious clinical signs, such as epistaxis, nasal congestion, and facial deformity. Radiation therapy is the treatment of choice but is not always accessible due to geographical location, logistics, or financial constraints. Other treatments may not be used because of various restrictions. We performed transnasal intranasal tumor volume reduction in 2 dogs with intranasal tumors; 1 dog had an adenocarcinoma and the other had a fibrosarcoma. In both cases, improvement in the quality of life (QOL), including reduced clinical signs and increased activity, was observed ~1 wk after treatment. No obvious complications were associated with this treatment. Although tumor recurrence was noted in both cases, this treatment could be applied multiple times. In conclusion, transnasal nasal tumor volume reduction is a palliative method that contributes to improvement of clinical signs and QOL. Key clinical message: We report palliative treatment of intranasal tumors in dogs. The treatment described in this report is available to most veterinarians and helps improve the QOL of dogs with nasal tumors, including improving respiratory status.</p>","PeriodicalId":9429,"journal":{"name":"Canadian Veterinary Journal-revue Veterinaire Canadienne","volume":"66 3","pages":"267-272"},"PeriodicalIF":0.9000,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11891793/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Canadian Veterinary Journal-revue Veterinaire Canadienne","FirstCategoryId":"97","ListUrlMain":"","RegionNum":4,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"VETERINARY SCIENCES","Score":null,"Total":0}
引用次数: 0
Abstract
Intranasal tumors in dogs are rare neoplastic diseases with obvious clinical signs, such as epistaxis, nasal congestion, and facial deformity. Radiation therapy is the treatment of choice but is not always accessible due to geographical location, logistics, or financial constraints. Other treatments may not be used because of various restrictions. We performed transnasal intranasal tumor volume reduction in 2 dogs with intranasal tumors; 1 dog had an adenocarcinoma and the other had a fibrosarcoma. In both cases, improvement in the quality of life (QOL), including reduced clinical signs and increased activity, was observed ~1 wk after treatment. No obvious complications were associated with this treatment. Although tumor recurrence was noted in both cases, this treatment could be applied multiple times. In conclusion, transnasal nasal tumor volume reduction is a palliative method that contributes to improvement of clinical signs and QOL. Key clinical message: We report palliative treatment of intranasal tumors in dogs. The treatment described in this report is available to most veterinarians and helps improve the QOL of dogs with nasal tumors, including improving respiratory status.
期刊介绍:
The Canadian Veterinary Journal (CVJ) provides a forum for the discussion of all matters relevant to the veterinary profession. The mission of the Journal is to educate by informing readers of progress in clinical veterinary medicine, clinical veterinary research, and related fields of endeavor. The key objective of The CVJ is to promote the art and science of veterinary medicine and the betterment of animal health.
A report suggesting that animals have been unnecessarily subjected to adverse, stressful, or harsh conditions or treatments will not be processed for publication. Experimental studies using animals will only be considered for publication if the studies have been approved by an institutional animal care committee, or equivalent, and the guidelines of the Canadian Council on Animal Care, or equivalent, have been followed by the author(s).